Insomnia Symptoms are Associated with Return to use and Non-fatal Overdose following Opioid Use Disorder Treatment.

Study Objectives: Opioid use disorder (OUD) is a chronic, relapse-prone condition, often accompanied by sleep disturbances such as insomnia. While sleep disturbances have been implicated in negative treatment outcomes, no large-scale studies have examined the relationship between insomnia disorder and outcomes for persons completing an acute OUD treatment episode. This study assessed the association between insomnia symptoms at treatment intake, during treatment, and following acute treatment with post-treatment episode return to use, and non-fatal overdose outcomes.

Divergence in cannabis and alcohol use disorder prevalence trends from 2002 to 2019.

Introduction: Despite increases in the availability, potency, and consumption of cannabis, epidemiological data suggest decreases in the prevalence of cannabis use disorder (CUD) in some groups. Understanding mechanisms for these changes may help improve diagnostic tools for identifying disordered use. This analysis evaluates changes in CUD compared to a substance with comparably stable social and environmental context (alcohol use disorder [AUD]) as well as treatment engagement and need from 2002 to 2019.

Evaluating the association between alcohol sweetness preference, alcohol harm, and alcohol value.

Alcohol use disorder is prevalent, and various risk factors inform drinking onset and drinking patterns. Existing data suggest that alcohol sweet taste preference may be associated with harmful levels of alcohol use and alcohol-related harm. The present exploratory study aimed to characterize people's first alcohol use experience, probe the association between sweet taste preferences and drinking patterns over time, and evaluate the relationship between sweet taste preferences and behavioral economic variables.

A comprehensive review on oral nicotine pouches: Available scientific evidence and future research needs.

Oral nicotine pouches (ONPs) are an emergent class of tobacco products that, unlike conventional oral smokeless tobacco products, contain a nicotine powder instead of tobacco leaves. This review synthesizes available data on ONPs in key research domains including survey studies, marketing/advertising studies, chemical characterization and in vitro studies, and clinical studies. Research findings relevant for ONP regulations are summarized, including who uses these products and why, how marketing tactics influence appeal and use intentions, what harmful and potentially harmful constituents they contain, and what acute effects they have on humans.